Skip to main navigation
logo
logo

Investors

Press Releases

Press Releases

Date Title Format
March 2, 2021 Chinook Therapeutics to Present at Upcoming Investor Conferences
PDF Version
March 1, 2021 Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney Diseases
PDF Version
February 23, 2021 Chinook Therapeutics to Present at 3rd Annual Chronic Kidney Disease Drug Development (CKD3) Summit
PDF Version
February 17, 2021 Chinook Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
PDF Version
February 2, 2021 Chinook Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for CHK-336 for Treatment of Primary Hyperoxaluria
PDF Version
January 4, 2021 Chinook Therapeutics to Present at Upcoming Investor Conferences
PDF Version

IR Contact

Noopur Liffick

Vice President
Investor Relations & Corporate Communications
investors@chinooktx.com
510.809.2465

Email Alerts

Required fields denoted by an asterisk ().
Alert type

Click here to unsubscribe from email alerts

  • Overview
  • Press Releases
  • Events & Presentations
  • Governance
  • Financials & Filings
  • Analyst Coverage
  • Stock Information
  • FAQs
  • Home
  • About Us
    • Overview
    • Purpose & Values
    • Leadership
    • Board of Directors
  • Pipeline
    • Pipeline
    • Atrasentan
    • BION-1301
    • CHK-336
    • Platform
    • Legacy Programs
    • Scientific Publications
    • Partnering Opportunities
  • Patients
    • Clinical Trials
    • Patient Resources
    • Advocacy Partners
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
      • SEC Filings
      • Annual Reports
    • Analyst Coverage
    • Stock Information
    • FAQs
  • Join Us
    • Join Our Team
    • Spotlights
    • Job Opportunities
    • Life at Chinook
  • Contact
    • Home
    • About Us
      • Overview
      • Purpose & Values
      • Leadership
      • Board of Directors
    • Pipeline
      • Pipeline
      • Atrasentan
      • BION-1301
      • CHK-336
      • Platform
      • Legacy Programs
      • Scientific Publications
      • Partnering Opportunities
    • Patients
      • Clinical Trials
      • Patient Resources
      • Advocacy Partners
    • Investors
      • Press Releases
      • Events & Presentations
      • Corporate Governance
      • Financials & Filings
        • SEC Filings
        • Annual Reports
      • Analyst Coverage
      • Stock Information
      • FAQs
    • Join Us
      • Join Our Team
      • Spotlights
      • Job Opportunities
      • Life at Chinook
    • Contact
      © 2021 Chinook Therapeutics, Inc.. All rights reserved
      • Terms of Use
      • Privacy Policy
      Website Design: Hane Chow, Inc.